Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome
Hepatology International, 04/09/2012Obulhasim G et al.
This study identifies that DNA–binding protein A (dbpA) may accelerate the hepatocarcinogenesis in hepatocellular carcinoma (HCC) patients with metabolic syndrome (MS) via inflammation–induced and oxidative stress pathways. The demethylation–related epigenetic activation may be one of the regulating factors for HCC patients with MS.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.